Log in to save this analysis

Save This Analysis

What do these columns mean?
Shared genes
Curated genes linked to both diseases (disease_gdp). The line below it shows how many of those are "corroborated" -- backed by 2+ independent database sources combined across both diseases, not resting on a single source's say-so.
Similarity score
Jaccard-based: shared genes ÷ the union of both diseases' entire gene sets, with a small boost from users who bookmarked both diseases. Treats both diseases symmetrically.
Overlap coefficient
Shared genes ÷ the smaller disease's own total gene count. Complements the similarity score above for asymmetric pairs -- e.g. a rare disease almost entirely "contained" in a common disease's much larger gene set scores low on Jaccard but high here.
P-value / FDR q-value
Is this gene overlap more than chance? An upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pair (the q-value is the one that accounts for testing thousands of pairs at once -- prefer it over the raw p-value).
Shared cluster
Links to a multi-disease cluster (see Disease Clusters) if both diseases of this pair were independently grouped together by that separate analysis.
ⓘ Shows only pairs whose gene overlap is too large to be down to chance (FDR q-value below 0.05). These are the rows marked ✓ sig. in the table. ⓘ Shows only pairs where both diseases also belong to the same group on the Disease Clusters page. Two separate analyses agree they're related, so the link is stronger. These are the rows with a link in the Shared cluster column.
0 selected Clear
Disease A ⇵Disease B ⇵Shared genes ⇵Similarity score ⇵Overlap coefficient ⇵P-value ⇵FDR q-value ▲ Shared cluster
Long qt syndrome Oculopharyngodistal myopathy
1 gene
Show details
1 of 1 corroborated by 2+ sources
LRP12(6)
0.009 0.200 3.27e-2 3.47e-2 ✓ sig. —
Lewis lung carcinoma Lung neoplasms
1 gene
Show details
LECT2(1)
0.004 0.500 3.27e-2 3.47e-2 ✓ sig. —
Tourette syndrome Trichotillomania
1 gene
Show details
1 of 1 corroborated by 2+ sources
SLITRK1(5)
0.004 0.500 3.32e-2 3.52e-2 ✓ sig. —
Substance abuse xeroderma pigmentosum group E
1 gene
Show details
1 of 1 corroborated by 2+ sources
DDB2(2)
0.002 1.000 3.35e-2 3.55e-2 ✓ sig. —
cardiomyopathy, dilated, 2j Substance abuse
1 gene
Show details
1 of 1 corroborated by 2+ sources
FLII(2)
0.002 1.000 3.35e-2 3.55e-2 ✓ sig. —
Intellectual developmental disorder dysmorphic facial hearing joint Substance abuse
1 gene
Show details
1 of 1 corroborated by 2+ sources
TET3(2)
0.002 1.000 3.35e-2 3.55e-2 ✓ sig. —
myopathy caused by variation in POMGNT2 Substance abuse
1 gene
Show details
1 of 1 corroborated by 2+ sources
POMGNT2(2)
0.002 1.000 3.35e-2 3.55e-2 ✓ sig. —
neurodevelopmental disorder with language impairment and behavioral abnormalities Substance abuse
1 gene
Show details
1 of 1 corroborated by 2+ sources
GRIA2(2)
0.002 1.000 3.35e-2 3.55e-2 ✓ sig. —
neurodevelopmental disorder with or without seizures and gait abnormalities Substance abuse
1 gene
Show details
1 of 1 corroborated by 2+ sources
GRIA4(2)
0.002 1.000 3.35e-2 3.55e-2 ✓ sig. —
neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia Substance abuse
1 gene
Show details
1 of 1 corroborated by 2+ sources
MED27(2)
0.002 1.000 3.35e-2 3.55e-2 ✓ sig. —
Cohen-gibson syndrome Substance abuse
1 gene
Show details
1 of 1 corroborated by 2+ sources
EED(6)
0.002 1.000 3.35e-2 3.55e-2 ✓ sig. —
HELIOS deficiency Substance abuse
1 gene
Show details
1 of 1 corroborated by 2+ sources
IKZF2(2)
0.002 1.000 3.35e-2 3.55e-2 ✓ sig. —
hermansky-pudlak syndrome 5 Substance abuse
1 gene
Show details
1 of 1 corroborated by 2+ sources
HPS5(2)
0.002 1.000 3.35e-2 3.55e-2 ✓ sig. —
Beck-fahrner syndrome Substance abuse
1 gene
Show details
1 of 1 corroborated by 2+ sources
TET3(6)
0.002 1.000 3.35e-2 3.55e-2 ✓ sig. —
Bilateral cleft lip Substance abuse
1 gene
Show details
1 of 1 corroborated by 2+ sources
PLEKHA5(2)
0.002 1.000 3.35e-2 3.55e-2 ✓ sig. —
Bosch-boonstra-schaaf optic atrophy syndrome Breast neoplasms
1 gene
Show details
1 of 1 corroborated by 2+ sources
NR2F1(5)
0.002 1.000 3.36e-2 3.55e-2 ✓ sig. —
Breast neoplasms muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A13
1 gene
Show details
1 of 1 corroborated by 2+ sources
B4GAT1(2)
0.002 1.000 3.36e-2 3.55e-2 ✓ sig. —
Breast neoplasms Thoracic malformation
1 gene
Show details
1 of 1 corroborated by 2+ sources
FGF4(3)
0.002 1.000 3.36e-2 3.55e-2 ✓ sig. —
Breast neoplasms Uric acid urolithiasis
1 gene
Show details
1 of 1 corroborated by 2+ sources
ZNF365(2)
0.002 1.000 3.36e-2 3.55e-2 ✓ sig. —
Breast neoplasms Uridine-cytidineuria
1 gene
Show details
1 of 1 corroborated by 2+ sources
SLC28A1(3)
0.002 1.000 3.36e-2 3.55e-2 ✓ sig. —
Breast neoplasms Corpus callosum agenesis with intellectual disability, coloboma, micrognathia
1 gene
Show details
1 of 1 corroborated by 2+ sources
IGBP1(5)
0.002 1.000 3.36e-2 3.55e-2 ✓ sig. —
Breast neoplasms Corpus callosum agenesis with intellectual disability, ocular coloboma, micrognathia
1 gene
Show details
1 of 1 corroborated by 2+ sources
IGBP1(3)
0.002 1.000 3.36e-2 3.55e-2 ✓ sig. —
Breast neoplasms Hereditary sensory and autonomic neuropathy with spastic paraplegia
1 gene
Show details
1 of 1 corroborated by 2+ sources
CCT5(3)
0.002 1.000 3.36e-2 3.55e-2 ✓ sig. —
Breast neoplasms hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency
1 gene
Show details
1 of 1 corroborated by 2+ sources
HRG(2)
0.002 1.000 3.36e-2 3.55e-2 ✓ sig. —
Breast neoplasms Hypotrichosis and recurrent skin vesicles
1 gene
Show details
1 of 1 corroborated by 2+ sources
DSC3(3)
0.002 1.000 3.36e-2 3.55e-2 ✓ sig. Cluster 5 →

Showing 25 of 20813 pairs, sorted by significance (ascending). Click a column header to sort.